Since the human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS), was first identified in the United States more than 30 years ago, expanded treatment options have brought down death rates, increased patient adherence, improved the quality of life for patients and paved the way for future research focused on preventing the disease.
Today there are 52 medicines and vaccines for HIV currently in development, including additional combination treatments, more effective therapies, and preventative vaccines. These medicines and vaccines are either in clinical trials or awaiting review by the FDA. Among the 52 medicines in development for HIV, there are 32 antiretrovirals and antivirals, 16 vaccines and four cell therapies, including a potential first-in-class medicine intended to prevent HIV from attaching to new cells and breaking through the cell membrane.
Watch: Together - HIV/AIDS
Interested in reading more on Medicines in Development for HIV 2017 Report?
Get your free copy of the report now.